NCT00054028View on ClinicalTrials.gov

Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Recurrent Breast CancerStage IIIB Breast CancerStage IV Breast Cancer
Interventions
DRUG

suramin

Given IV

DRUG

paclitaxel

Given IV

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00054028 - Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer | Biotech Hunter | Biotech Hunter